Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
A depot injection is a long-acting formulation that releases medicine gradually from an injection site. It is commonly administered into a muscle or under the skin, depending on the product. The formulation creates or acts as a reservoir from which the active drug enters the bloodstream over days, weeks, or months. This allows less frequent dosing than many immediate-release injections or oral medicines.
read more about depot injection ...Depot injections are used for long-term treatment, prevention, or symptom control when sustained drug exposure is useful. Examples include certain antipsychotics, hormonal contraceptives, cancer treatments, corticosteroids, medicines for opioid use disorder, and other long-acting therapies. They can reduce the need for daily dosing and make adherence easier to assess. The approved uses and dosing interval vary widely among products.
A depot formulation slows the movement of active drug away from the injection site. Oils, crystals, salts, polymers, microspheres, or other technologies can control dissolution, breakdown, or release. The drug is then absorbed into the circulation over an extended period. Release can be affected by the formulation, injection route, tissue blood flow, dose, and patient characteristics.
Depot injections are administered by trained personnel using the product's specified route, site, needle, preparation method, and schedule. Some products require refrigeration, shaking, reconstitution, oral test dosing, or temporary overlap with an oral medicine. Doses can be scheduled every few weeks or months, although the interval is product specific. Missed-dose instructions must be followed because restarting treatment can require a different plan.
Benefits include less frequent administration, steadier drug exposure, and reduced reliance on daily medication. Possible problems include injection-site pain, swelling, nodules, infection, bleeding, and product-specific systemic adverse effects. Once administered, the dose usually cannot be removed, and adverse effects can continue while the depot releases medicine. Incorrect injection technique or missed monitoring can also change absorption, effectiveness, or safety.
No. Many intramuscular injections release medicine quickly, while a depot formulation is specifically designed for prolonged release. Some depot injections are administered subcutaneously rather than intramuscularly.
Depending on the product, one dose can release medicine for days, weeks, or several months. The labeled interval does not apply to every depot medicine.
Usually not. Once injected, the formulation generally continues releasing medicine until the depot is depleted or broken down by the body.
Some begin acting soon, while others take time to reach an effective concentration. Certain products require an oral test dose, loading regimen, or temporary oral overlap.
Long-Acting Injectable Antipsychotics: A Review on Formulation and In Vitro Dissolution. Pharmaceutics (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC10820045/. Date Accessed August 5, 2026.
DEPO-PROVERA CI (Medroxyprogesterone Acetate) Injectable Suspension: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=199cf13e-0859-4a73-9b45-e700d0cd1049. Date Accessed August 5, 2026.
ABILIFY MAINTENA (Aripiprazole) Extended-Release Injectable Suspension: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6. Date Accessed August 5, 2026.
ARISTADA (Aripiprazole Lauroxil) Extended-Release Injectable Suspension: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb. Date Accessed August 5, 2026.
SUBLOCADE (Buprenorphine Extended-Release) Injection: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6189fb21-9432-45f8-8481-0bfaf3ccde95. Date Accessed August 5, 2026.